Want to see IL:TMRP full AI Analyst Report?
Top Page
Tamar Pet
(TASE:TMRP)
Select Model
Select Model
Rating:69Neutral
Price Target:
2,629.00
▼(-38.14% Downside)
Action:Reiterated
Date:05/27/26
The score is driven primarily by strong financial performance (healthy margins and solid cash generation) and supportive valuation (high dividend yield and moderate P/E). These positives are tempered by weak technicals, including a below-trend price versus key moving averages and negative MACD, indicating unfavorable near-term momentum.
Positive Factors
Profitability / Margins
Sustained gross and net margins (TTM gross ~33%, net ~17%) indicate the business captures strong spreads versus costs, providing durable earnings power. High margins support reinvestment, dividend capacity and resilience through commodity-related revenue swings over months.
Negative Factors
Revenue Volatility
Choppy and declining revenue (TTM down, Fundamentals show -13.14% growth) signals sensitivity to commodity cycles and demand swings. Persistent top-line variability limits predictability of earnings and cash flow, complicating long-term planning and investment.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability / Margins
Sustained gross and net margins (TTM gross ~33%, net ~17%) indicate the business captures strong spreads versus costs, providing durable earnings power. High margins support reinvestment, dividend capacity and resilience through commodity-related revenue swings over months.
Read all positive factors
Tamar Pet (TMRP) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪2.19B
Dividend Yield7.38%
Average Volume (3M)105.64K
Price to Earnings (P/E)18.7
Beta (1Y)1.17
Revenue Growth-13.14%
EPS Growth-26.30%
CountryIL
Employees8
SectorGeneral
Sector StrengthN/A
IndustryOil & Gas Exploration & Production
Share Statistics
EPS (TTM)0.49
Shares Outstanding89,268,910
10 Day Avg. Volume98,824
30 Day Avg. Volume105,641
Financial Highlights & Ratios
PEG Ratio-4.16
Price to Book (P/B)2.36
Price to Sales (P/S)3.86
P/FCF Ratio9.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Tamar Pet Business Overview & Revenue Model
Company Description
Tamar Petroleum Ltd engages in the exploration, development, production, marketing, and transmission of natural gas and condensate in Israel. It has 16.75% interest rights in the Tamar and Dalit projects. The company sells and supplies natural gas...
Tamar Pet Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
68
Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 277.51M | 273.78M | 310.44M | 234.02M | 302.19M | 238.94M |
| Gross Profit | 118.05M | 173.93M | 110.27M | 197.19M | 117.71M | 100.27M |
| EBITDA | 214.66M | 219.44M | 157.04M | 144.99M | 158.89M | 131.26M |
| Net Income | 43.44M | 53.84M | 58.56M | 49.51M | 33.82M | 39.68M |
Balance Sheet | ||||||
| Total Assets | 1.20B | 1.20B | 1.22B | 1.22B | 1.27B | 1.28B |
| Cash, Cash Equivalents and Short-Term Investments | 68.08M | 69.29M | 23.22M | 32.17M | 83.06M | 94.06M |
| Total Debt | 635.13M | 642.98M | 699.00M | 751.96M | 804.30M | 855.57M |
| Total Liabilities | 840.45M | 753.23M | 796.47M | 829.40M | 903.69M | 937.55M |
| Stockholders Equity | 355.06M | 448.08M | 427.78M | 392.77M | 362.26M | 346.16M |
Cash Flow | ||||||
| Free Cash Flow | 133.87M | 110.58M | 89.64M | 47.62M | 161.65M | 136.80M |
| Operating Cash Flow | 181.39M | 135.43M | 156.18M | 89.70M | 167.76M | 139.21M |
| Investing Cash Flow | 55.50M | 2.49M | -47.36M | -21.74M | -63.65M | -4.71M |
| Financing Cash Flow | -198.13M | -98.49M | -118.30M | -116.20M | -116.02M | -133.28M |
Tamar Pet Technical Analysis
Neutral
4250.00
Price Trends
2632.20
Positive
2907.08
Negative
3188.85
Negative
Market Momentum
35.20
Negative
62.52
Neutral
83.67
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:TMRP, the sentiment is Neutral. The current price of 4250 is above the 20-day moving average (MA) of 2531.80, above the 50-day MA of 2632.20, and above the 200-day MA of 3188.85, indicating a neutral trend. The MACD of 35.20 indicates Negative momentum. The RSI at 62.52 is Neutral, neither overbought nor oversold. The STOCH value of 83.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:TMRP.
Tamar Pet Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₪2.19B | 18.69 | ― | 7.38% | -13.14% | -26.30% | |
69 Neutral | ₪4.77B | 14.63 | 27.38% | 8.82% | -30.57% | -32.49% | |
68 Neutral | ₪18.14B | 26.55 | 24.33% | 3.95% | -30.64% | -59.45% | |
61 Neutral | ₪14.12B | 4.29 | 4.49% | 6.64% | -27.59% | 190.27% | |
59 Neutral | ₪14.95B | 31.49 | ― | ― | 584.71% | 855.02% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IL:TMRP
Tamar Pet
2,845.00
-933.86
-24.71%
IL:NWMD
Newmed Energ Pu
1,564.00
55.64
3.69%
IL:DLEKG
Delek Group
77,470.00
12,219.08
18.73%
IL:ISRA
Isramco Pu
193.80
-25.88
-11.78%
IL:RATI
Ratio Pu
426.60
-12.83
-2.92%
IL:NVPT
Navitas Ptro Pu
12,710.00
1,877.67
17.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.